Antithrombotics in Patients With a Femoral Neck Fracture: Evaluating Daily Practice in an Observational Cohort Study

Introduction Geriatric hip fracture patients are characterized by frailty due to multiple comorbidities, such as cardiovascular disease, in which the use of antithrombotics is frequent. The aim of this study is to assess the effect of antithrombotics on perioperative care and patient outcomes after...

Full description

Bibliographic Details
Main Authors: Veronique A. J. I. M. van Rijckevorsel MD, Gert R. Roukema MD, Taco M. A. L. Klem MD, PhD, Tjallingius M. Kuijper MD, PhD, Louis de Jong MD
Format: Article
Language:English
Published: SAGE Publishing 2021-08-01
Series:Geriatric Orthopaedic Surgery & Rehabilitation
Online Access:https://doi.org/10.1177/21514593211037755
_version_ 1818357492707491840
author Veronique A. J. I. M. van Rijckevorsel MD
Gert R. Roukema MD
Taco M. A. L. Klem MD, PhD
Tjallingius M. Kuijper MD, PhD
Louis de Jong MD
author_facet Veronique A. J. I. M. van Rijckevorsel MD
Gert R. Roukema MD
Taco M. A. L. Klem MD, PhD
Tjallingius M. Kuijper MD, PhD
Louis de Jong MD
author_sort Veronique A. J. I. M. van Rijckevorsel MD
collection DOAJ
description Introduction Geriatric hip fracture patients are characterized by frailty due to multiple comorbidities, such as cardiovascular disease, in which the use of antithrombotics is frequent. The aim of this study is to assess the effect of antithrombotics on perioperative care and patient outcomes after hip hemiarthroplasty following current guidelines. Materials and Methods This observational cohort study included all consecutively admitted patients with a femoral neck fracture requiring hip hemiarthroplasty between January 1 st 2010, and May 16 th 2016, in two level II trauma teaching hospitals. Patients with multiple trauma injuries were excluded. Results In total, n = 907 patients (68% female (n = 615), median age 84 years) were included of which n = 142 used a vitamin K antagonist (VKA) and n = 213 used antiplatelet (AP) therapy. Both were associated with more packed cell supplementation (.4 ± 1.1 units and .3 ± .8 units vs .2 ± .6 units, P < .001 and P = .03, respectively). VKA was associated with more hematomas compared no antithrombotics (23% vs 11%, P = .001). VKA had a longer time to surgery compared to no antithrombotics and AP (24 hours vs 19 and 20 hours, P < .001 and P < .001, respectively) and longer admission duration (9 days vs 7 days P < .001. There were no differences in 30 day mortality nor in 1-year mortality rates. Discussion All modifiable causes for deep SSI, such as hematomas, should be prevented in acute hip fracture surgery. Since antithrombotics are associated with hematomas, an optimal handling in perioperative setting is necessary. Conclusion VKA was associated with longer time to surgery, more hematomas, and longer admission duration. VKA and AP were associated with more packed cell supplementation.
first_indexed 2024-12-13T20:13:58Z
format Article
id doaj.art-969bcc57f1ef48519bf12c3837689dc6
institution Directory Open Access Journal
issn 2151-4593
language English
last_indexed 2024-12-13T20:13:58Z
publishDate 2021-08-01
publisher SAGE Publishing
record_format Article
series Geriatric Orthopaedic Surgery & Rehabilitation
spelling doaj.art-969bcc57f1ef48519bf12c3837689dc62022-12-21T23:32:51ZengSAGE PublishingGeriatric Orthopaedic Surgery & Rehabilitation2151-45932021-08-011210.1177/21514593211037755Antithrombotics in Patients With a Femoral Neck Fracture: Evaluating Daily Practice in an Observational Cohort StudyVeronique A. J. I. M. van Rijckevorsel MDGert R. Roukema MDTaco M. A. L. Klem MD, PhDTjallingius M. Kuijper MD, PhDLouis de Jong MDIntroduction Geriatric hip fracture patients are characterized by frailty due to multiple comorbidities, such as cardiovascular disease, in which the use of antithrombotics is frequent. The aim of this study is to assess the effect of antithrombotics on perioperative care and patient outcomes after hip hemiarthroplasty following current guidelines. Materials and Methods This observational cohort study included all consecutively admitted patients with a femoral neck fracture requiring hip hemiarthroplasty between January 1 st 2010, and May 16 th 2016, in two level II trauma teaching hospitals. Patients with multiple trauma injuries were excluded. Results In total, n = 907 patients (68% female (n = 615), median age 84 years) were included of which n = 142 used a vitamin K antagonist (VKA) and n = 213 used antiplatelet (AP) therapy. Both were associated with more packed cell supplementation (.4 ± 1.1 units and .3 ± .8 units vs .2 ± .6 units, P < .001 and P = .03, respectively). VKA was associated with more hematomas compared no antithrombotics (23% vs 11%, P = .001). VKA had a longer time to surgery compared to no antithrombotics and AP (24 hours vs 19 and 20 hours, P < .001 and P < .001, respectively) and longer admission duration (9 days vs 7 days P < .001. There were no differences in 30 day mortality nor in 1-year mortality rates. Discussion All modifiable causes for deep SSI, such as hematomas, should be prevented in acute hip fracture surgery. Since antithrombotics are associated with hematomas, an optimal handling in perioperative setting is necessary. Conclusion VKA was associated with longer time to surgery, more hematomas, and longer admission duration. VKA and AP were associated with more packed cell supplementation.https://doi.org/10.1177/21514593211037755
spellingShingle Veronique A. J. I. M. van Rijckevorsel MD
Gert R. Roukema MD
Taco M. A. L. Klem MD, PhD
Tjallingius M. Kuijper MD, PhD
Louis de Jong MD
Antithrombotics in Patients With a Femoral Neck Fracture: Evaluating Daily Practice in an Observational Cohort Study
Geriatric Orthopaedic Surgery & Rehabilitation
title Antithrombotics in Patients With a Femoral Neck Fracture: Evaluating Daily Practice in an Observational Cohort Study
title_full Antithrombotics in Patients With a Femoral Neck Fracture: Evaluating Daily Practice in an Observational Cohort Study
title_fullStr Antithrombotics in Patients With a Femoral Neck Fracture: Evaluating Daily Practice in an Observational Cohort Study
title_full_unstemmed Antithrombotics in Patients With a Femoral Neck Fracture: Evaluating Daily Practice in an Observational Cohort Study
title_short Antithrombotics in Patients With a Femoral Neck Fracture: Evaluating Daily Practice in an Observational Cohort Study
title_sort antithrombotics in patients with a femoral neck fracture evaluating daily practice in an observational cohort study
url https://doi.org/10.1177/21514593211037755
work_keys_str_mv AT veroniqueajimvanrijckevorselmd antithromboticsinpatientswithafemoralneckfractureevaluatingdailypracticeinanobservationalcohortstudy
AT gertrroukemamd antithromboticsinpatientswithafemoralneckfractureevaluatingdailypracticeinanobservationalcohortstudy
AT tacomalklemmdphd antithromboticsinpatientswithafemoralneckfractureevaluatingdailypracticeinanobservationalcohortstudy
AT tjallingiusmkuijpermdphd antithromboticsinpatientswithafemoralneckfractureevaluatingdailypracticeinanobservationalcohortstudy
AT louisdejongmd antithromboticsinpatientswithafemoralneckfractureevaluatingdailypracticeinanobservationalcohortstudy